Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ANAC > SEC Filings for ANAC > Form 8-K/A on 28-Mar-2013All Recent SEC Filings

Show all filings for ANACOR PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K/A for ANACOR PHARMACEUTICALS INC


28-Mar-2013

Regulation FD Disclosure, Other Events, Financial Statements and Exh


ITEM 7.01 REGULATION FD DISCLOSURE.

On March 21, 2013, Anacor Pharmaceuticals, Inc. hosted a conference call to discuss the results from a Phase 2 clinical trial of AN2728 for the treatment of adolescents with atopic dermatitis. A copy of slides that are supplemental to the conference call is furnished and attached as Exhibit 99.2.

The information in Item 7.01 and Exhibit 99.2 of this Current Report is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.



ITEM 8.01 OTHER EVENTS.

On March 21, 2013, Anacor Pharmaceuticals, Inc. issued a press release announcing results from a Phase 2 clinical trial of AN2728 for the treatment of adolescents with atopic dermatitis. A copy of such press release in connection with this conference call is attached as Exhibits 99.1 and is incorporated herein by reference.



ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

Exhibit
Number                                  Description
99.1      Press Release titled "Anacor Pharmaceuticals Announces Positive Results
          From Phase 2 Dose-Ranging Study of AN2728 in Adolescents with Atopic
          Dermatitis" dated March 21, 2013
99.2      Anacor Pharmaceuticals, Inc. Conference Call Slides March 21, 2013


  Add ANAC to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ANAC - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.